DVT

Inovia Vein Expands Outpatient Vein Care Services in Northwest Portland

Retrieved on: 
星期三, 十月 11, 2023
General Health, Health, Surgery, Cardiology, Diagnosis, Pacific Northwest, MD, DVT, Varicose veins, Trauma, General surgery, Thrombosis, Patient, Quality of life, Medical imaging

Dr. Nagamoto will be focusing entirely on providing high quality outpatient vein care services for common vein disorders such as varicose veins, vein ulcers, spider veins, and the diagnosis and management of Deep Venous Thrombosis (DVT).

Key Points: 
  • Dr. Nagamoto will be focusing entirely on providing high quality outpatient vein care services for common vein disorders such as varicose veins, vein ulcers, spider veins, and the diagnosis and management of Deep Venous Thrombosis (DVT).
  • "I am so pleased to join Inovia Vein at their Northwest Portland location," said Dr. Nagamoto.
  • About Inovia Vein Specialty Centers: Inovia Vein Specialty Centers is a leading provider of specialized vein care services, offering state-of-the-art treatments for various vein disorders, including varicose veins, vein ulcers, spider veins, and Deep Venous Thrombosis.
  • With a commitment to excellence, Inovia Vein is dedicated to improving the quality of life for patients across the Northwest by delivering compassionate, innovative, and effective vein care solutions.

Inovia Vein Specialty Centers Commemorates World Thrombosis Day: Spreading Awareness on Deep Vein Thrombosis (DVT)

Retrieved on: 
星期三, 十月 11, 2023
General Health, Health, Surgery, Cardiology, Pain, Knowledge, Common, Tenderness, Prevalence, Vein, DVT, Travel, System, Swelling, Education, SE, Deep vein thrombosis, Pulmonary embolism, Red, Leg, Learning, Skin, Patient, Nursing, Birth control, Poultry farming, Tourism, Bend

As the world comes together to observe World Thrombosis Day on October 13th, 2023, Inovia Vein Specialty Centers proudly joins the global campaign to raise awareness about the prevalence and risks associated with Deep Vein Thrombosis (DVT).

Key Points: 
  • As the world comes together to observe World Thrombosis Day on October 13th, 2023, Inovia Vein Specialty Centers proudly joins the global campaign to raise awareness about the prevalence and risks associated with Deep Vein Thrombosis (DVT).
  • Inovia Vein Specialty Centers is dedicated to educating our communities about DVT, its signs, symptoms, and treatment options.
  • Deep Vein Thrombosis (DVT) occurs when blood clots form in the deep veins of the legs or other parts of the body.
  • About Inovia Vein Specialty Centers: Inovia Vein Specialty Centers is a leading provider of vein care services, committed to delivering top-quality care for patients with venous diseases.

World Thrombosis Day encourages public to "Move Against Thrombosis" to celebrate 10 years of raising awareness worldwide

Retrieved on: 
星期五, 十月 13, 2023
Foot, Coronary thrombosis, ISTH, Thrombosis, Death, International Society, Tenderness, Chest pain, Pelvis, Uterus, Organization, VTE, DVT, Hospital, Travel, Pregnancy, Calf, Heart rate, Cancer, Movement, Blood, Thrombus, Pulmonary embolism, International Society on Thrombosis and Haemostasis, Patient, Walking, Leg, Deep vein thrombosis, Vein, Ankle, Risk, Birth control

World Thrombosis Day engages 5,000 partner organizations from 120 countries to advance understanding of the treatment and prevention of blood clots.

Key Points: 
  • World Thrombosis Day engages 5,000 partner organizations from 120 countries to advance understanding of the treatment and prevention of blood clots.
  • For its 10th anniversary year, the campaign encourages people to Move Against Thrombosis with simple movements to increase blood flow.
  • Thrombosis can develop in, or travel to, blood vessels throughout the body, often causing symptoms that can be mistaken for other conditions.
  • Incorporating movement in blood clot prevention inspired World Thrombosis Day's Move Against Thrombosis theme.

World Thrombosis Day encourages public to "Move Against Thrombosis" to celebrate 10 years of raising awareness worldwide

Retrieved on: 
星期五, 十月 13, 2023
Foot, Coronary thrombosis, ISTH, Thrombosis, Death, International Society, Tenderness, Chest pain, Pelvis, Uterus, Organization, VTE, DVT, Hospital, Travel, Pregnancy, Calf, Heart rate, Cancer, Movement, Blood, Thrombus, Pulmonary embolism, International Society on Thrombosis and Haemostasis, Patient, Leg, Deep vein thrombosis, Vein, Ankle, Risk, Birth control

World Thrombosis Day engages 5,000 partner organizations from 120 countries to advance understanding of the treatment and prevention of blood clots.

Key Points: 
  • World Thrombosis Day engages 5,000 partner organizations from 120 countries to advance understanding of the treatment and prevention of blood clots.
  • For its 10th anniversary year, the campaign encourages people to Move Against Thrombosis with simple movements to increase blood flow.
  • Thrombosis can develop in, or travel to, blood vessels throughout the body, often causing symptoms that can be mistaken for other conditions.
  • Incorporating movement in blood clot prevention inspired World Thrombosis Day's Move Against Thrombosis theme.

Los Angeles Vascular Surgeon, Varicose & Spider Vein Treatment Specialist Dr. Rameen Moridzadeh Receives Castle Connolly's 2023 Top Doctor® Award

Retrieved on: 
星期一, 十月 2, 2023
Vein, Aneurysm, Varicose veins, University School, PAD, DVT, Castle Connolly Medical, Multimedia, Artery, Sclerotherapy, Carotid artery stenosis, Blood, Hospital, Patient, Division, Physician, New York University Grossman School of Medicine, Laser, Deep vein thrombosis, Castle, Diagnosis, LOS, Cedars-Sinai Medical Center, UCLA, Nursing, Medical device

LOS ANGELES, Oct. 2, 2023 /PRNewswire-PRWeb/ -- Rameen Moridzadeh, M.D. has been selected as a 2023 Top Doctor® by Castle Connolly. He has earned this impressive award for his expertise as one of the top vein specialists and vascular surgeons in Los Angeles, CA. Dr. Moridzadeh's medical education, training, hospital appointments and disciplinary history were rigorously screened by the Castle Connolly physician-led research team. Castle Connolly publishes its list of Top Doctors at http://www.castleconnolly.com and in a wide variety of partner publications, magazines and affiliate websites. Around 5% of the nation's licensed physicians have been selected as Castle Connolly Top Doctors in their regions for their specialties. Individuals do not and cannot pay to be selected as a Castle Connolly Top Doctor. Dr. Moridzadeh is a fellowship-trained and board-certified vascular and endovascular surgeon well-known for successfully treating conditions affecting veins, arteries and other blood vessels. He specializes in minimally invasive options and surgical procedures to improve vascular health and can offer an accurate diagnosis, delivering the best care possible. He has performed thousands of treatments for varicose veins, peripheral artery disease (PAD), carotid artery stenosis, aortic aneurysms, deep vein thrombosis (DVT), spider veins and chronic venous insufficiency at his clinics and hospitals. Dr. Moridzadeh offers RF ablation, sclerotherapy, laser therapy and vascular surgery for his patients, many of which require little to no downtime after the procedure.

Key Points: 
  • LOS ANGELES, Oct. 2, 2023 /PRNewswire-PRWeb/ -- Rameen Moridzadeh, M.D.
  • has been selected as a 2023 Top Doctor® by Castle Connolly.
  • He has earned this impressive award for his expertise as one of the top vein specialists and vascular surgeons in Los Angeles, CA.
  • Dr. Moridzadeh's medical education, training, hospital appointments and disciplinary history were rigorously screened by the Castle Connolly physician-led research team.

Inteleos Unveils Two New Point-of-Care Ultrasound Certifications

Retrieved on: 
星期二, 九月 26, 2023
IVC, European Information Technologies Certification Academy, Critical care, Arm, Education, DVT, Venae cavae, Inferior vena cava, Lung, Certification, POCUS, PCA, AAA, Health, Abdominal trauma, Abdominal aortic aneurysm, Nursing

ROCKVILLE, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Inteleos, a non-profit global healthcare certification organization, through its Point-of-Care Ultrasound (POCUS) Certification Academy (PCA), today announced the launch of an Inferior Vena Cava (IVC) certification and a Critical Care Specialty certification.

Key Points: 
  • ROCKVILLE, Md., Sept. 26, 2023 (GLOBE NEWSWIRE) -- Inteleos, a non-profit global healthcare certification organization, through its Point-of-Care Ultrasound (POCUS) Certification Academy (PCA), today announced the launch of an Inferior Vena Cava (IVC) certification and a Critical Care Specialty certification.
  • The PCA provides certification and educational resources for clinicians and is dedicated to ensuring quality patient care globally by upholding ultrasound standards with independently validated certifications.
  • The IVC Clinical Certificate and the Critical Care Specialty Certification include case-based assessments that simulate real-life clinical encounters and peer evaluations that determine practical skills and the user’s ability to interpret and diagnose findings.
  • “POCUS is not just an imaging tool, it's a compassionate touchpoint in patient care and a revolution in healthcare.

New Telit Cinterion Wi-Fi 6/ Bluetooth® Low Energy Module Enables Rapid Development and Time to Market for Smart Devices

Retrieved on: 
星期四, 九月 14, 2023
Yee, Product management, Bluetooth Low Energy, Wi-Fi, Realtek, Wi-Fi 6, Internet, Original equipment manufacturer, PCI Express, Wi-Fi Alliance, USB, DVT, WLAN, Wireless LAN, Certification, MIMO, IEEE, Bluetooth Special Interest Group, MAC, Wireless, Multi, RF, EVT, Consumer electronics, Bluetooth

The WE310K6 enables device OEMs to add high-speed wireless connectivity quickly and cost-effectively to their products — even when they have limited Bluetooth and Wi-Fi expertise.

Key Points: 
  • The WE310K6 enables device OEMs to add high-speed wireless connectivity quickly and cost-effectively to their products — even when they have limited Bluetooth and Wi-Fi expertise.
  • The WE310K6 supports 802.11 a/b/g/n/ac/ax, classic Bluetooth and Bluetooth Low Energy 5.2, giving OEMs the flexibility to design products that can connect to other local devices or to the internet over Wi-Fi.
  • OEMs can get new products to market faster by reducing RF design time and removing the burden of testing and certification.
  • "Our new WE310K6 enables them to add low-power quickly and cost-effectively, high-performance connectivity even when they have only limited RF design expertise.

Global Clot Management Devices Market Share, Trends, Opportunities, Competition, and Forecasts, 2018-2023 & 2023-2028 - ResearchAndMarkets.com

Retrieved on: 
星期二, 九月 12, 2023
Medical Devices, Health, Surgery, General Health, Pharmaceutical, Cardiology, PE, Regional basketball competitions in Spain, Hip, Prevalence, Pulmonary embolism, Stroke, Tetraplegia, Cardiovascular disease, DVT, Ageing, Cancer, Research, Competition, Compound annual growth rate, Thrombectomy, Incidence, Hospital, AIDS, Deep vein thrombosis, Growth, Diagnosis, WHO, Smoking, Knee, World Health Organization, Medical device, Video game, Dietary supplement, Birth control

The global clot management devices market is projected to experience consistent growth with a steady Compound Annual Growth Rate (CAGR) throughout the forecast period from 2024 to 2028.

Key Points: 
  • The global clot management devices market is projected to experience consistent growth with a steady Compound Annual Growth Rate (CAGR) throughout the forecast period from 2024 to 2028.
  • Advancements in clot management device technologies aimed at enhancing the diagnosis and treatment of conditions like stroke, coupled with the increasing preference for minimally invasive medical procedures, are driving the demand for clot management devices within the market.
  • The United States commands a dominant position in the global clot management devices market.
  • Company Profiles: Detailed analysis of the major companies present in Global Clot Management Devices Market.

Allegro DVT Launches a New Generation of High-Performance Multi-Format Video Encoder IP for 4K/8K Video Resolutions

Retrieved on: 
星期二, 九月 12, 2023
Apps, Applications, Technology, Satellite, Other Technology, Photography, Telecommunications, Audio, Video, Internet, Data Management, Architecture, AV1, IPS, Silicon, ROI, VP9, JPEG, Memory, SOC, HEVC, E300, Television, Computer data storage, DVT

Allegro DVT , a leading provider of video encoding semiconductor IP solutions, today announced the availability of its E300 series, a new generation of video encoder IPs built upon a higher performance architecture with support for resolutions from 4K60 up to 8K120.

Key Points: 
  • Allegro DVT , a leading provider of video encoding semiconductor IP solutions, today announced the availability of its E300 series, a new generation of video encoder IPs built upon a higher performance architecture with support for resolutions from 4K60 up to 8K120.
  • The E300 series of encoder IPs implements an enhanced hardware architecture that unlocks unprecedented video throughputs and introduces the best trade-offs between video quality and real-time performance.
  • “ Allegro DVT has a proven track record in providing cutting-edge and scalable video IPs with best-in-class video quality, silicon area and power consumption.
  • To find out more about the E300 series, come and visit Allegro DVT booth 5.A25 at IBC Amsterdam 15-18 September 2023.

Labwise by Allegro DVT Introduces the First DVB-TTML Subtitling Test Suite

Retrieved on: 
星期四, 九月 7, 2023
Entertainment, Apps, Applications, Technology, TV and Radio, Other Technology, Audio, Video, Software, Consortium, Original equipment manufacturer, DVT, Hybrid Broadcast Broadband TV, DVB, DASH, SMPTE, Traction, Digital, ATSC, ETSI, TTML, Cable television, Television

Labwise by Allegro DVT, the leader in Digital TV Testing & Video Decoder Compliance announces the availability of the industry’s first DVB-TTML Test Suite which enables testing of the mandatory DVB-TTML Subtitling Systems Specification specified in ETSI EN 303 560 V1.1.1.

Key Points: 
  • Labwise by Allegro DVT, the leader in Digital TV Testing & Video Decoder Compliance announces the availability of the industry’s first DVB-TTML Test Suite which enables testing of the mandatory DVB-TTML Subtitling Systems Specification specified in ETSI EN 303 560 V1.1.1.
  • DVB TTML was developed by the Digital Video Broadcasting Project, an industry Consortium that sets standards for digital television broadcasting.
  • TTML has gained significant traction within broadcasters and content providers worldwide to provide standardized captioning and subtitling practices.
  • "We see the release of our DVB-TTML Test Suite as a major step to foster the deployment of this new subtitling format.